4//SEC Filing
Upnorth Investment Ltd 4
Accession 0000899243-19-004398
CIK 0001750019other
Filed
Feb 20, 7:00 PM ET
Accepted
Feb 21, 4:54 PM ET
Size
17.1 KB
Accession
0000899243-19-004398
Insider Transaction Report
Form 4
Upnorth Investment Ltd
10% Owner
Transactions
- Conversion
Common Stock
2019-02-19+1,614,517→ 1,937,419 total(indirect: By Upnorth Investment Limited) - Conversion
Series A Preferred Stock
2019-02-19−2,000,000→ 0 total(indirect: By Upnorth Investment Limited)→ Common Stock (322,902 underlying) - Conversion
Series B Preferred Stock
2019-02-19−10,000,000→ 0 total(indirect: By Upnorth Investment Limited)→ Common Stock (1,614,517 underlying) - Conversion
Common Stock
2019-02-19+322,902→ 322,902 total(indirect: By Upnorth Investment Limited) - Purchase
Common Stock
2019-02-19$15.00/sh+200,000$3,000,000→ 2,137,419 total(indirect: By Upnorth Investment Limited)
China Molybdenum (Hong Kong) Co Ltd
10% Owner
Transactions
- Conversion
Series B Preferred Stock
2019-02-19−10,000,000→ 0 total(indirect: By Upnorth Investment Limited)→ Common Stock (1,614,517 underlying) - Conversion
Common Stock
2019-02-19+1,614,517→ 1,937,419 total(indirect: By Upnorth Investment Limited) - Conversion
Series A Preferred Stock
2019-02-19−2,000,000→ 0 total(indirect: By Upnorth Investment Limited)→ Common Stock (322,902 underlying) - Conversion
Common Stock
2019-02-19+322,902→ 322,902 total(indirect: By Upnorth Investment Limited) - Purchase
Common Stock
2019-02-19$15.00/sh+200,000$3,000,000→ 2,137,419 total(indirect: By Upnorth Investment Limited)
China Molybdenum Co., Ltd.
10% Owner
Transactions
- Conversion
Common Stock
2019-02-19+1,614,517→ 1,937,419 total(indirect: By Upnorth Investment Limited) - Purchase
Common Stock
2019-02-19$15.00/sh+200,000$3,000,000→ 2,137,419 total(indirect: By Upnorth Investment Limited) - Conversion
Series B Preferred Stock
2019-02-19−10,000,000→ 0 total(indirect: By Upnorth Investment Limited)→ Common Stock (1,614,517 underlying) - Conversion
Common Stock
2019-02-19+322,902→ 322,902 total(indirect: By Upnorth Investment Limited) - Conversion
Series A Preferred Stock
2019-02-19−2,000,000→ 0 total(indirect: By Upnorth Investment Limited)→ Common Stock (322,902 underlying)
Footnotes (3)
- [F1]Each share of Series A Preferred Stock converted into shares of the Issuer's common stock, par value $0.0001 ("Common Stock"), on a 6.1938:1 basis upon the closing of the Issuer's initial public offering.
- [F2]The reported securities are owned directly by Upnorth Investment Limited. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein.
- [F3]Each share of Series B Preferred Stock converted into shares of the Issuer's Common Stock on a 6.1938:1 basis upon the closing of the Issuer's initial public offering.
Documents
Issuer
TCR2 THERAPEUTICS INC.
CIK 0001750019
Entity typeother
IncorporatedVirgin Islands, British
Related Parties
1- filerCIK 0001766474
Filing Metadata
- Form type
- 4
- Filed
- Feb 20, 7:00 PM ET
- Accepted
- Feb 21, 4:54 PM ET
- Size
- 17.1 KB